Literature DB >> 19623871

Natural history of brucellosis in an endemic region in different time periods.

Mile Bosilkovski1, Marija Dimzova, Krsto Grozdanovski.   

Abstract

The aim of the study was to determine the evolution and outcome of human brucellosis in an endemic region in relation to time interval. Retrospective analysis was employed to compare demographic, epidemiological, clinical, laboratory features and the outcome of patients with brucellosis, treated at University Department of Infectious Diseases in Skopje during two different periods of time. A series of 159 patients were studied in the first (1990-1991) and 138 in the second (2003-2005) study period. Patients treated in the second period were older (34.6+/-20.9 vs. 30.0+/-17.7 years; P=0.041) and acquired brucellosis less frequently on ingestion of incriminated food (34.8% vs. 47.2%; P=0.031). Focal forms were more evident in the second period (66.7% vs. 50.3%; P=0.004), mainly due to osteoarticular localization. Post-treatment follow up was more efficient in the second group (76.1% vs. 61%; P=0.005). There was no difference according to disease outcome in spite of different therapeutic trials during the two study periods. In conclusion, the established differences showed an improvement in the understanding of the disease by the general population as well as upgrading of some aspects considering medical activities. Nevertheless, this endemic region still lacks the most important measure, i.e. development and implementation of an appropriate national program for efficient control of the disease.

Entities:  

Mesh:

Year:  2009        PMID: 19623871

Source DB:  PubMed          Journal:  Acta Clin Croat        ISSN: 0353-9466            Impact factor:   0.780


  21 in total

1.  Seropositivity in animals and risk of occupational brucellosis among abattoirs personnel associated with poor work practices and absence of safety policy in Egypt.

Authors:  Amira M Zakaria; Salwa F Ahmed; Mohamed S Motawae
Journal:  Int J Occup Environ Health       Date:  2018-09-17

2.  Spinal epidural abscess in brucellosis.

Authors:  Ahmet Boyaci; Nurefsan Boyaci; Ahmet Tutoglu; Dilek Sen Dokumaci
Journal:  BMJ Case Rep       Date:  2013-09-26

3.  Epidemiological characteristics of brucellosis in Federation of Bosnia and Herzegovina.

Authors:  Zarema Obradović; Ramiz Velić
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

4.  Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.

Authors:  Mile Bosilkovski; Ljiljana Krteva; Marija Dimzova; Ivan Vidinic; Zaklina Sopova; Katerina Spasovska
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

5.  Splenic abscess due to acute brucellosis.

Authors:  Mehmet Deveer; Hamdi Sozen; Nesat Çullu; Ali Kemal Sivrioglu
Journal:  BMJ Case Rep       Date:  2013-04-10

6.  Spontaneous bacterial peritonitis by Brucella in a cirrhotic patient.

Authors:  Alexandre Oliveira Ferreira; Luis Nogueira Martins; Rui Tato Marinho; José Velosa
Journal:  BMJ Case Rep       Date:  2013-04-05

7.  Neurobrucellosis in systemic lupus erythematosus.

Authors:  Jamshid Vafaeimanesh; Alireza Shahamzeh; Mohammad Bagherzadeh
Journal:  Caspian J Intern Med       Date:  2017

Review 8.  Acute liver failure complication of brucellosis infection: a case report and review of the literature.

Authors:  Julio César García Casallas; Walter Villalobos Monsalve; Sara Consuelo Arias Villate; Ingrid Marisol Fino Solano
Journal:  J Med Case Rep       Date:  2018-03-09

9.  Clinical manifestations, laboratory findings, and therapeutic regimen in hospitalized children with brucellosis in an Iranian Referral Children Medical Centre.

Authors:  Fatemeh Fanni; Leila Shahbaznejad; Babak Pourakbari; Shima Mahmoudi; Setareh Mamishi
Journal:  J Health Popul Nutr       Date:  2013-06       Impact factor: 2.000

10.  Cytopenia in adult brucellosis patients.

Authors:  Safak Kaya; Nazif Elaldi; Ozcan Deveci; Ahmet Emre Eskazan; Muhammed Bekcibasi; Salih Hosoglu
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.